Quanterix (QTRX) Change in Accured Expenses (2017 - 2026)
Quanterix (QTRX) posted Change in Accured Expenses of -$7.3 million for Q1 2026, down 250.94% on a QoQ basis from -$2.1 million in Q4 2025, and down 106.26% year-over-year from $116.0 million in Q1 2025.
Quanterix (QTRX) Change in Accured Expenses (2017 - 2026) Analysis & Trends
Quanterix's Change in Accured Expenses history runs 10 years deep, the most recent figure standing at -$7.3 million for Q1 2026.
- Quarterly Change in Accured Expenses fell 106.26% year-over-year to -$7.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$11.7 million (down 385.49% YoY) and the FY2025 annual result came in at -$7.9 million, down 666.09% from the prior year.
- Change in Accured Expenses was -$7.3 million for Q1 2026 at Quanterix, down from -$2.1 million in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $5.1 million in Q2 2025 and bottomed at -$7.5 million in Q3 2025.
- A 5-year average of -$762294.1 and a median of $616000.0 in 2022 frame the typical range for Change in Accured Expenses.
- Annual changes were most pronounced in 2023 — Change in Accured Expenses soared 672.08% — and 2025, when it plunged 751.4%.
- Quanterix's Change in Accured Expenses stood at -$685000.0 in 2022, then soared by 564.38% to $3.2 million in 2023, then surged by 43.48% to $4.6 million in 2024, then slumped by 145.29% to -$2.1 million in 2025, then slumped by 250.94% to -$7.3 million in 2026.
- Business Quant data shows QTRX's Change in Accured Expenses at -$7.3 million in Q1 2026, -$2.1 million in Q4 2025, and -$7.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -347.10 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 145.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 21.07 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -250.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Quanterix | 184.16 Mn | 84.89 Mn | 15.57 Mn | -7.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.25 Mn |
| Mar 31, 2026 | -7.25 Mn |
| Dec 31, 2025 | -2.07 Mn |
| Dec 31, 2025 | -2.07 Mn |
| Sep 30, 2025 | -7.45 Mn |
| Sep 30, 2025 | -7.45 Mn |
| Jun 30, 2025 | 5.12 Mn |
| Jun 30, 2025 | 5.12 Mn |
| Mar 31, 2025 | -3.52 Mn |
| Mar 31, 2025 | -3.52 Mn |
| Dec 31, 2024 | 4.56 Mn |
| Dec 31, 2024 | 4.56 Mn |
| Sep 30, 2024 | 1.14 Mn |
| Sep 30, 2024 | 1.14 Mn |
| Jun 30, 2024 | 1.89 Mn |
| Jun 30, 2024 | 1.89 Mn |
| Mar 31, 2024 | -6.20 Mn |
| Mar 31, 2024 | -6.20 Mn |
| Dec 31, 2023 | 3.18 Mn |
| Dec 31, 2023 | 3.18 Mn |